Mackenzie's Mission HomepageMackenzie's Mission

What Is Amyloidosis

A Clinical & Patient Perspective of Wild-Type Amyloidosis

In this special video, hear world-renowned expert Dr. Mathew S. Maurer and his patient John Basdavanos presenting to a group of medical students. Dr. Maurer provides a brief overview of Wild-Type Amyloidosis (ATTRwt), while John provides the patient perspective. Together, these insights offer a compelling story about battling a life threatening disease.

CRISPR/Cas9 – Editing the Code of Life

The scientific world is abuzz … a Nobel Prize-winning technology called CRISPR/Cas9 can now edit our DNA. This programmable gene-editing technology, which is efficient, precise, and scalable, has inspired a gold rush of countless applications in medicine, agriculture and basic science.  In this blog we invite you to read more about this ground-breaking advance and how, with one course of treatment, it could potentially cure hereditary transthyretin (hATTR / ATTRv) amyloidosis.

AI, Protein Folding & Amyloidosis

AI is rapidly advancing the knowledge of protein misfolding, unlocking answers for amyloidosis which should lead to earlier diagnosis, improved treatment, and better patient survival.

Not Just A Game: Protein Structure Prediction

One of the greatest biological challenges science has faced is predicting the shape of proteins from its component amino acids. With the number of possible configurations estimated to be 10 to the power of 300, the answers seemed unreachable. Until now.